期刊
CLINICAL IMMUNOLOGY
卷 215, 期 -, 页码 -出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.clim.2020.108423
关键词
-
类别
Aim of the present study was to investigate the possible involvement of TNF-alpha signaling pathway and T-lymphocyte activation in DN. Eighty-two diabetic patients [39 male, age 69.5(56-78)years] were divided into three groups, according to Albumin/Creatinine ratio (ACR) levels, Group I (ACR < 30 mu g/mg), Group II (ACR 30-300 mu g/mg), Group III (ACR > 300 mu g/mg). Urinary Tumor Necrosis Factor-alpha (TNF-alpha), and serum TNF-alpha, TNF-receptor 1 (TNFR1), TNFR2, B7-1, CD28, Cytoxic T-Lymphocyte-Associated protein-4 (CTLA4), were estimated. There were significant differences between Groups I, II, III regarding the concentration of urinary TNF-alpha (p < .001), serum TNFR1 (p < .001), serum TNFR2(p < .001), CTLA4 (p < .001) and CD28(p = .034). In multivariate analysis, independent parameters correlated with ACR were serum TNFR1 (p = .003), TNFR2 (p = .012) and urinary TNF-alpha (p = .015) levels. There was a significant correlation between markers of T-cell activation and TNF-alpha signaling pathway activation. Activation of TNF-alpha signaling pathway and T-lymphocytes seem to synergize and participate in the development of DN in type II DM.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据